Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-03-07
1991-04-23
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514220, 540495, 540509, C07D52100, A61K 3155
Patent
active
050100769
ABSTRACT:
Compounds corresponding to the formula I ##STR1## in which R.sup.1 represents hydrogen, lower alkyl or cycloalkylalkyl with 4-7 carbon atoms,
REFERENCES:
patent: 4567177 (1986-01-01), Bigg et al.
patent: 4628084 (1986-12-01), Bock et al.
patent: 4820834 (1989-04-01), Evans et al.
Chemical Abstracts 105:107944z.
Chemical Abstracts 109:204385h.
Journal of Heterocyclic Chemistry, vol. 11, No. 3, pp. 387-393 (1974).
Benson Werner
Gregory Peter-Colin
Hamminga Derk
Van Wijngaarden Ineke
Waldeck Harald
Bond Robert T.
Kali-Chemie Pharma GmbH
LandOfFree
1,7-fused 1H-indole-2-carboxylic acid-N-(1,4-benzodiazepin-3-yl) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,7-fused 1H-indole-2-carboxylic acid-N-(1,4-benzodiazepin-3-yl), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,7-fused 1H-indole-2-carboxylic acid-N-(1,4-benzodiazepin-3-yl) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1621521